Cellebrite CEO awarded 38,505 share units

The units are scheduled to vest in installments starting May 4, 2027, with vesting every three months through May 4, 2030.

Rhea-AI Filing Summary

Cellebrite DI Ltd. (CLBT) Chief Executive Officer and director Ramji Shiven acquired an award of 38,505 restricted share units on September 24, 2026. Each unit represents a contingent right to receive one ordinary share upon settlement, and the reported direct position following the award was 462,055 ordinary shares. The units vest in installments beginning May 4, 2027; no Rule 10b5-1 plan is reported.

Insider Trade Summary

Grant/Award: 38,505 shares

Grant/Award 1 txn

Insider Ramji Shiven

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary shares, par value NIS 0.00001 F1	38,505	$0.00	$0.00

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 462,055 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted share units ("RSUs") that will vest as follows: 9,633 vest on May 4, 2027 and 2,406 vest every three months thereafter through May 4, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Key Figures

Restricted share units awarded: 38,505 units Direct position following award: 462,055 ordinary shares First vesting installment: 9,633 units +1 more

4 metrics

Restricted share units awarded 38,505 units Awarded September 24, 2026

Direct position following award 462,055 ordinary shares Reported after the September 24, 2026 award

First vesting installment 9,633 units Vest May 4, 2027

Subsequent vesting installments 2,406 units Vest every three months thereafter through May 4, 2030

Key Terms

restricted share units, contingent right, settlement

3 terms

restricted share units financial

"award of restricted share units"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"contingent right to receive one Ordinary Share"

settlement financial

"upon settlement"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many restricted share units did CLBT CEO Ramji Shiven receive?

Ramji Shiven acquired an award of 38,505 restricted share units on September 24, 2026. Each unit represents a contingent right to receive one ordinary share upon settlement, and the reported direct position following the award was 462,055 ordinary shares.

What is the vesting schedule for Ramji Shiven's CLBT RSU award?

9,633 units vest on May 4, 2027, and 2,406 vest every three months thereafter through May 4, 2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/25/2026 - 04:16 PM Accepted by SEC EDGAR 09/25/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ramji Shiven

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	09/24/2026		A		38,505(1)	A	$0	462,055	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted share units ("RSUs") that will vest as follows: 9,633 vest on May 4, 2027 and 2,406 vest every three months thereafter through May 4, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Remarks:

	/s/ Shiven Ramji	09/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)